Smoking as a major risk factor for cervical cancer and pre-cancer: Results from the EPIC cohort
2013/12/14 by Esther Roura, Xavier Castellsagué, Michael Pawlita +56 · 26 citations
Medicine · #Cervical Cancer and HPV Research #Endometrial and Cervical Cancer Treatments #Cancer Risks and Factors
paper · pdf · doi:10.1002/ijc.28666
Abstract
A total of 308,036 women were selected from the European Prospective Investigation into Cancer and Nutrition (EPIC) study to evaluate the association between tobacco smoking and the risk of cervical intraepithelial neoplasia of grade 3 (CIN3)/carcinoma in situ (CIS) and invasive cervical cancer (ICC). At baseline, participants completed a questionnaire and provided blood samples. During a mean follow-up time of 9 years, 261 ICC cases and 804 CIN3/CIS cases were reported. In a nested case-control study, the baseline sera from 609 cases and 1,218 matched controls were tested for L1 antibodies against HPV types 11, 16, 18, 31, 33, 35, 45, 52, 58, and antibodies against Chlamydia trachomatis (CT), and Human Herpes Virus 2 (HHV-2). Cervical samples were not available for HPV-DNA analysis in this study. Multivariate analyses were used to estimate associations between smoking and risk of CIN3/CIS and ICC in the cohort and the case-control studies. In the cohort analyses smoking status, duration and intensity showed a two-fold increased risk of CIN3/CIS and ICC, while time since quitting was associated with a two-fold reduced risk. In the nested case-control study, consistent associations were observed after adjustment for HPV, CT and HHV-2 serostatus, in both HPV seronegative and seropositive women. Results from this large prospective study confirm the role of tobacco smoking as an important risk factor for both CIN3/CIS and ICC, even after taking into account HPV exposure as determined by HPV serology. The strong beneficial effect of quitting smoking is an important finding that will further support public health policies for smoking cessation.
Citations
Cited by
- Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint EHTG-ESCP revision
- Human papillomavirus 16 non-European variants are preferentially associated with high-grade cervical lesions. [europepmc]
- Prevalence and risk factors for cervical neoplasia: a cervical cancer screening program in Beijing. [europepmc]
- Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology. [europepmc]
- Genome Analysis of Latin American Cervical Cancer: Frequent Activation of the PIK3CA Pathway. [europepmc]
- The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort. [europepmc]
- Metabolic effects of smoking cessation. [europepmc]
- The Intersection of HPV Epidemiology, Genomics and Mechanistic Studies of HPV-Mediated Carcinogenesis. [europepmc]
- Perceptions of Continued Smoking and Smoking Cessation Among Patients With Cancer. [europepmc]
- Surveillance for Cancers Associated with Tobacco Use - United States, 2010-2014. [europepmc]
- The relation of passive smoking with cervical cancer: A systematic review and meta-analysis. [europepmc]
- Validation of Multiplex Serology detecting human herpesviruses 1-5. [europepmc]
- Cervicovaginal microbiome and natural history of HPV in a longitudinal study. [europepmc]
- Comprehensive gene and pathway analysis of cervical cancer progression. [europepmc]
- Cancer cases and deaths attributable to lifestyle risk factors in Chile. [europepmc]
- Cervical cancer: Epidemiology, risk factors and screening. [europepmc]
- Gender differences within the barriers to smoking cessation and the preferences for interventions in primary care a qualitative study using focus groups in The Hague, The Netherlands. [europepmc]
- Secondhand smoke exposure, diabetes, and high BMI are risk factors for uterine cervical cancer: a cross-sectional study from the Korea national health and nutrition examination survey (2010-2018). [europepmc]
- Pharmacological Modulation of Ubiquitin-Proteasome Pathways in Oncogenic Signaling. [europepmc]
- Essentiality of Trace Elements in Pregnancy, Fertility, and Gynecologic Cancers-A State-of-the-Art Review. [europepmc]
- Trends in the Incidence of Human Papillomavirus-Associated Cancers by County-Level Income and Smoking Prevalence in the United States, 2000-2018. [europepmc]
- HPV and Cervical Cancer: A Review of Epidemiology and Screening Uptake in the UK. [europepmc]
- Cervical Cancer Screening Recommendations: Now and for the Future. [europepmc]
- Uptake of human papilloma virus vaccine and its determinants among females in East Africa: a systematic review and meta-analysis. [europepmc]
- Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint EHTG-ESCP revision. [europepmc]
- Global burden of gynaecological cancers in 2022 and projections to 2050. [europepmc]
Related